Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Mar;27(3):e70059.
doi: 10.1111/codi.70059.

Total neoadjuvant therapy in early-onset rectal cancer: A multicentre prospective cohort study

Sergei Bedrikovetski  1   2 , Ishraq Murshed  1   2 , Tracy Fitzsimmons  1   2 , Luke Traeger  1   2 , Timothy J Price  3 , Michael Penniment  4 , Sudarshan Selva-Nayagam  5 , Ryash Vather  2   6 , Tarik Sammour  1   2
Affiliations
Multicenter Study

Total neoadjuvant therapy in early-onset rectal cancer: A multicentre prospective cohort study

Sergei Bedrikovetski et al. Colorectal Dis. 2025 Mar.

Abstract

Aim: The incidence of early-onset (age <50 years) rectal cancer (EORC) is rising globally, often presenting at an advanced stage. Total neoadjuvant therapy (TNT) is increasingly utilised in the management of advanced rectal cancers due to improved response and survival rates. However, it remains unclear whether EORC in an unscreened population responds similarly to TNT compared to average or late-onset (age ≥50 years) rectal cancer (AORC).

Method: This study included consecutive patients treated with curative intent with TNT for rectal cancer at three South Australian hospitals between 2019 and 2024. Patients were divided into EORC and AORC cohorts. The primary outcome was overall complete response (oCR) rate, defined as the proportion of patients who achieved a clinical complete response (cCR) and/or pathological complete response (pCR). Secondary outcomes included compliance and treatment-related toxicity.

Results: Of 202 eligible patients, 48 (23.8%) were in the EORC cohort and 154 (76.2%) in the AORC cohort. No significant difference in oCR rate was observed between EORC and AORC patients (43.8% vs. 37.9%, P = 0.470). cCR, pCR and complete M1 response rates were also similar between the two groups. EORC patients experienced significantly less Grade 3-4 chemotherapy-induced toxicity compared to AORC patients (2.1% vs. 25.3%, P < 0.001), but reported higher rates of patient-reported Grade 3-4 radiotherapy-induced toxicity than AORC patients (31.3% vs. 12.3%, P = 0.004).

Conclusion: EORC patients exhibit comparable overall tumour response rates to AORC patients treated with TNT. However, toxicity profiles differ, with EORC patients experiencing less chemotherapy-induced toxicity but more patient-reported radiation-induced toxicity.

Keywords: average‐onset; clinical complete response; early‐onset; pathological complete response; rectal cancer; total neoadjuvant therapy.

PubMed Disclaimer

Conflict of interest statement

The author(s) have no affiliations or financial involvement with any organisation or entity with financial interest. This manuscript was accepted as a poster presentation at the 93rd RACS 2025 Annual Scientific Congress, 3‐6 May 2025 in Sydney, Australia.

Figures

FIGURE 1
FIGURE 1
Study flow chart.
See this image and copyright information in PMC

References

    1. Murphy CC, Sandler RS, Sanoff HK, Yang YC, Lund JL, Baron JA. Decrease in incidence of colorectal cancer among individuals 50 years or older after recommendations for population‐based screening. Clin Gastroenterol Hepatol. 2017;15:903–909. e6. - PMC - PubMed
    1. Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, et al. Changes in colorectal cancer incidence in seven high‐income countries: a population‐based study. Lancet Gastroenterol Hepatol. 2019;4(7):511–518. 10.1016/S2468-1253(19)30147-5 - DOI - PMC - PubMed
    1. Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT, Merchea A. Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer. 2019;18:e87–e95. - PubMed
    1. Quinn TJ, Kabolizadeh P. Rectal cancer in young patients: incidence and outcome disparities. J Gastrointest Oncol. 2020;11:880–893. - PMC - PubMed
    1. Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez‐Bigas MA, Skibber JM, et al. Increasing disparities in the age‐related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg. 2015;150(1):17–22. 10.1001/jamasurg.2014.1756 - DOI - PMC - PubMed

Publication types

LinkOut - more resources